PharmaPlot is a privately owned company established in 2016, focused on the development, out- licensing and supply of high-quality generic pharmaceutical products and value-added medicines.
Our portfolio contains solid dosage forms (tablets & capsules), injectables, oral solutions and suspensions. We offer robust supply chains and a full range of services covering all stages of the pharmaceutical value chain, from product development to regulatory approval and life cycle management.
Having a team of specialists in the fields of pharmaceutical development, regulatory affairs, production, and commercialization of medicinal products, PharmaPlot has already accumulated significant know-how, intellectual property rights and products intended for commercialization in Europe and globally.
![TARGET](https://pharmaplot.com/wp-content/uploads/2023/10/TARGET-150x150.png)
Our mission is
to follow the advancement of science, technology and regulation and be able to provide to pharmaceutical companies around the world medicines of high-quality standards through a robust supply chain.